Ma et al. found that TRPM2-AS was overexpressed in A549 cells with cisplatin resistance and that TRPM2-AS knockdown could recover the cisplatin sensitivity in non-small cell lung cancer cells [16]. The gene discussed is TRPM2; the disease is non-small cell lung carcinoma.